Discovery and characterization of highly immunogenic and broadly recognized mimics of the HIV-1 CTL epitope Gag77-85

European Journal of Immunology

Volumn 35, Issue 5, 2005, Pages 1428-1437

  Boggiano, César ^a   Moya, Rosa ^a   Pinilla, Clemencia ^a   Bihl, Florian ^b   Brander, Christian ^b   Sidney, John ^c   Sette, Alessandro ^c   Blondelle, Sylvie E ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

CTL epitope; Cytotoxic T lymphocytes; Escape variant; HIV; Peptide library

Indexed keywords

EPITOPE; GAG PROTEIN; NONAPEPTIDE; PEPTIDE LIBRARY; PROTEIN P17;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; IN VIVO STUDY; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DATABASE; SEQUENCE ANALYSIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; CROSS REACTIONS; EPITOPES, T-LYMPHOCYTE; GENE PRODUCTS, GAG; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; MICE; MICE, TRANSGENIC; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; T-LYMPHOCYTES, CYTOTOXIC;

EID: 18844379375     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425903     Document Type: Article

References (35)

1. Spearman, P., HIV vaccine development: Lessons from the past and promise for the future. Curr. HIV Res. 2003. 1: 103-125.
2. Gaschen, B., Taylor, J., Yusim, K., Foley, B., Gao, F., Lang, D., Novitsky, V., Haynes, B., Hahn, B. H., Bhattacharya, T. and Korber, B., Diversity considerations in HIV-1 vaccine selection. Science 2002. 296: 2354-2360.
3. Nickle, D. C., Jensen, M. A., Gottlieb, G. S., Shriner, D., Learn, G. H., Rodrigo, A. G. and Mullins, J. I., Consensus and ancestral state HIV vaccines. Science 2003. 299: 1515-1517.
4. Sewell, A. K., Price, D. A., Oxenius, A., Kelleher, A. D. and Phillips, R. E., Cytotoxic T lymphocyte responses to human immunodeficiency virus: Control and escape. Stem Cells 2000. 18: 230-244.
5. Borrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A. and Shaw, G. M., Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 1997. 3: 205-211.
6. Cao, H., Hanki, P., Sankale, J. L., Dieng-Sarr, A., Mazzara, G. P., Kalams, S. A., Korber, B., Mboup, S. and Walker, B. D., Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: Implications for vaccine development. J. Virol. 1997. 71: 8615-8623.
7. Ferrari, G., Humphrey, W., McElrath, M. J., Excler, J., Duliege, A., Clements, M. L., Corey, L. C., Bolognesi, D. P. and Weinhold, K. J., Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. Proc. Natl. Acad. Sci. USA 1997. 94: 1396-1401.
8. Goulder, P. J. R., Sewell, A. K., Lalloo, D. G., Price, D. A., Whelan, J. A., Evans, J., Taylor, G. P., Luzzi, G., Giangrande, P., Phillips, R. E. and McMichael, A. J., Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation. J. Exp. Med. 1997. 185: 1423-1433.
9. Brander, C., Hartman, K. E., Trocha, A. K., Jones, N. G., Johnson, R. P., Korber, B., Wentworth, P., Buchbinder, S. P., Wolinsky, S., Walker, B. D. and Kalams, S. A., Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection. J. Clin. Invest. 1998. 101: 2559-2566.
10. Jamieson, B. D., Yang, O. O., Hultin, L., Hausner, M. A., Hultin, P., Matud, J., Kunstman, K., Killian, S., Altman, J., Kommander, K. et al., Epitope escape mutation and decay of human immunodeficiency virus type 1-specific CTL responses. J. Immunol. 2003. 171: 5372-5379.
11. Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Cerundolo, V. et al., Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998. 279: 2103-2106.
12. Kalams, S. A. and Walker, B. D., The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J. Exp. Med. 1998. 199: 2199-2204.
13. Goulder, P. J. R., Altfeld, M. A., Rosenberg, E. S., Nguyen, T., Tang, Y., Eldridge, R. L., Addo, M. M., He, S., Mukherjee, J. S., Phillips, M. N. et al., Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J. Exp. Med. 2001. 193: 181-193.
14. Kan-Mitchell, J., Bisikirska, B., Wong-Staal, F., Schaubert, K. L., Bajcz, M. and Bereta, M., The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope. J. Immunol. 2004. 172: 5249-5261.
15. Pinilla, C., Martin, R., Gran, B., Appel, J. R., Boggiano, C., Wilson, D. B. and Houghten, R. A., Exploring immunological specificity using synthetic peptide combinatorial libraries. Curr. Opin. Immunol. 1999. 11: 193-202.
16. Borras, E., Martin, R., Judkowski, V., Shukaliak, J., Zhao, Y., Rubio-Godoy, V., Valmori, D., Wilson, D., Simon, R., Houghten, R. and Pinilla, C., Findings on T cell specificity revealed by synthetic combinatorial libraries. J. Immunol. Methods 2002. 267: 79-97.
17. Rammensee, H.-G., Friede, T. and Stevanovic, S., MHC ligands and peptide motifs. Immunogenetics 1995. 41: 178-228.
18. Falk, K., Rotzschke, O., Stevanovic, S., Jung, G. and Rammensee, H.-G., Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991. 351: 290-296.
19. Brander, C., Yang, O. O., Jones, N. G., Lee, Y., Goulder, P., Johnson, R. P., Trocha, A., Colbert, D., Hay, C., Buchbinder, S. et al., Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences. J. Virol. 1999. 73: 10191-10198.
20. Zhao, Y., Gran, B., Pinilla, C., Markovic-Plese, S., Hemmer, B., Tzou, A., Whitney, L. W., Biddison, W. E., Martin, R. and Simon, R., Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands. J. Immunol. 2001. 167: 2130-2141.
21. Lustgarten, J., Theobald, M., Labadie, C., LaFace, D., Perterson, P., Disis, M. L., Cheever, M. A. and Sherman, L. A., Identification of Her-2/neu epitopes using double transgenic mice expressing HLA-A2.1 and human CD8. Hum. Immunol. 1997. 52: 109-118.
22. Korber, B., Walker, B., Brander, C., Koup, R., Moore, J., Haynes, B. and Meyers, G., HIV Molecular Immunology Database. Los Alamos National Laboratory: Theoretical Biology and Biophysics, Los Alamos, NM 1996
23. Phillips, R. E., Rowland-Jones, S., Nixon, D. F., Gotch, F. M., Edwards, J. P., Ogunlesi, A. O., Elvin, J. G., Rothbard, J. A., Bangham, C. R. M., Rizza, C. R. and McMichael, A. J., Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991. 354: 453-459.
24. Sette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W. M., Melief, C. J., Oseroff, C., Yuan, L., Ruppert, J. et al., The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 1994. 153: 5586-5592.
25. Lee, J. K., Stewart-Jones, G., Dong, T., Harlos, K., Di Gleria, K., Dorrell, L., Douek, D. C., van der Merwe, P. A., Jones, E. Y. and Mc.Michael, A. J., T cell cross-reactivity and conformational changes during TCR engagement. J. Exp. Med. 2004. 200: 1455-1466.
26. Wu, L. C., Tuot, D. S., Lyons, D. S., Garcia, K. C. and Davis, M. M., Two-step binding mechanism for T cell receptor recognition of peptide-MHC. Nature 2002. 418: 552-556.
27. Yang, O. O., Sarkis, P. T., Ali, A., Harlow, J. D., Brander, C., Kalams, S. A. and Walker, B. D., Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes. J. Exp. Med. 2003. 197: 1365-1375.
28. Kelleher, A. D., Long, C., Holmes, E. C., Allen, R. L., Wilson, J., Conlon, C., Workman, C., Shaunak, S., Olson, K., Goulder, P. et al., Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J. Exp. Med. 2001. 193: 375-385.
29. Denkberg, G., Klechevsky, E. and Reiter, Y., Modification of a tumor-derived peptide at an HLA-A2 anchor residue can alter the conformation of the MHC-peptide complex: Probing with TCR-like recombinant antibodies. J. Immunol. 2002. 169: 4399-4407.
30. Walker, B. D., Chakrabarti, S., Moss, B., Paradis, T. J., Flynn, T., Durno, A. G., Blumberg, R. S., Kaplan, J. C., Hirsch, M. S. and Schooley, R. T., HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 1987. 328: 345-348.
31. Sipsas, N. V., Kalams, S. A., Trocha, A., He, S., Blattner, W. A., Walker, B. D. and Johnson, R. P., Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1. J. Clin. Invest. 1997. 99: 752-762.
32. Salter, R. D., Howell, D. N. and Cresswell, P., Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 1985. 21: 235-246.
33. Brander, C., O'Connor, P., Suscovich, T., Jones, N. G., Lee, Y., Kedes, D., Ganem, D., Martin, J., Osmond, D., Southwood, S. et al., Definition of an optimal cytotoxic T lymphocyte epitope in the latently expressed Kaposi's sarcoma-associated herpesvirus kaposin protein. J. Infect. Dis. 2001. 184: 119-126.
34. Sidney, J., Southwood, S., Oseroff, C., del Guercio, M. F., Sette, A. and Grey, H., Measurement of MHC/peptide interactions by gel filtration. Curr. Protocols Immunol. 1998. 18.3.1-18.3.19.
35. Tangri, S., Ishioka, G. Y., Huang, X., Sidney, J., Southwood, S., Fikes, J. and Sette, A., Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide. J. Exp. Med. 2001. 194: 833-846.